Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

LatchBio

Explore full profile

Builds and disseminates free to use data infrastructure for the the biocomputing revolution

San Francisco, United StatesFounded 2021Biotech & Life Sciences
Valuation $100–250M Last recorded · 2022
Revenue $100–500M Latest reported FY
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for LatchBio and the history behind them.

About LatchBio

Latch.bio is a cloud-based platform that provides a comprehensive solution for biotech companies to manage and analyze their data. It serves hundreds of biotech firms, helping them accelerate their research and development (R&D) milestones by making data analysis faster, cheaper, and more accessible.

The platform offers a range of features including data storage, organization, transformation, and analysis. It allows companies to store unlimited amounts of raw data, eliminating data silos and boosting collaboration. The platform also provides a simple interface for exploring analysis results, making it easier for scientists to make quick decisions on their experiments.

Latch.bio also offers a customizable data platform, giving companies control and flexibility over their data while eliminating the time and cost of infrastructure setup. It also provides mission-critical security, ensuring the safe processing of data at an extreme scale for data storage or bioinformatics workflows.

The business model of Latch.bio is based on providing a one-stop solution for all data needs of biotech companies, replacing multiple platforms at a fraction of the cost. It makes money by charging these companies for using its platform.

In addition, Latch.bio offers features for workflow orchestration. Companies can set up workflows in minutes and scale them to thousands of cores. They can also control their own analysis and run workflows through a simple user interface. This helps save on cloud costs by automatically running on optimized instances.

In summary, Latch.bio is a flexible and secure platform that helps biotech companies accelerate their R&D milestones by making data analysis faster, cheaper, and more accessible.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
San Francisco, United States
Employees
41
Open positions
9
Dealroom signal
95.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Drug Development, Synthetic Biology, Sustainable Development Goals, Tech for Biotech and Pharma, Biotech and Pharma, Climate Tech, Techbio, Techbio Drug Discovery, Digital Pharma
Business model
SaaS
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2026 $130M $500M Undisclosed ↗
SERIES AOther financing Jun 2022 $28M $112M Haystack · Caffeinated Capital · Lux Capital · Hummingbird Ventures ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

LatchBio website traffic

Latest recorded traffic for LatchBio is 29K monthly website visits, up 81.3% over the last three months. LatchBio's team grew 173.3% over the past year.

Latest monthly visits29K 3-month web change+81.3% 1-year team growth+173.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

Series A3 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about LatchBio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LatchBio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.